Activity of DSA against anaerobically adapted Mycobacterium bovis BCG in vitro.
DSA is a beta-sulfonylacetamide with in vitro activity against pathogenic mycobacteria. Although the enzymatic target(s) of DSA has not been identified, studies to date suggest that this class of compounds may interfere directly or indirectly with ATP synthase and other components of the mycobacterial respiratory chain. In this study we further evaluated the in vitro activity of DSA against anaerobically adapted BCG using two established models. DSA killed BCG in the anaerobic Wayne model. Bactericidal activity ranged from >99% to 60%. DSA killed rifampin-tolerant persisters with a reduction in viable counts of 1.5log(10) versus controls. Conclusive identification of the DSA-specific target(s) will permit a better understanding of the unique mechanism of action of this class of compounds against both aerobically growing and anaerobically adapted bacilli in vitro.
Parrish
Nicole M
NM
Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA. nparrish@jhmi.edu
Ko
Chiew G
CG
Dick
James D
JD
D000222:Adaptation, Physiological; D000693:Anaerobiosis; D000995:Antitubercular Agents / Q000494:pharmacology*; D009163:Mycobacterium bovis / Q000187:drug effects* / Q000254:growth & development; D013449:Sulfonamides / Q000494:pharmacology*
D000995:Antitubercular Agents; D013449:Sulfonamides; C554367:n-decanesulfonylacetamide